John Wilkin
Stock Analyst at Craig-Hallum
(1.28)
# 4,062
Out of 5,178 analysts
6
Total ratings
50%
Success rate
-2.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Buy | $12 → $10 | $2.79 | +258.42% | 2 | Mar 11, 2026 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $13.96 | +7.45% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $32.80 | +37.20% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $7.32 | +9.29% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $4.62 | +527.71% | 1 | Feb 12, 2025 |
Exagen
Mar 11, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $2.79
Upside: +258.42%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $13.96
Upside: +7.45%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $32.80
Upside: +37.20%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $7.32
Upside: +9.29%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $4.62
Upside: +527.71%